Stocks and Investing Stocks and Investing
Wed, April 25, 2018
Tue, April 24, 2018
Mon, April 23, 2018
Fri, April 20, 2018
Thu, April 19, 2018
Wed, April 18, 2018
Tue, April 17, 2018
Mon, April 16, 2018

David Nierengarten Maintained (BPMC) at Buy with Increased Target to $106 on, Apr 16th, 2018


Published on 2024-10-26 04:33:12 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Increased Target from $98 to $106 on, Apr 16th, 2018.

David, nor any peers, have made any analyst calls on BPMC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Similar Stocks and Investing Articles